U.S. flag

An official website of the United States government

NM_000335.5(SCN5A):c.3232T>A (p.Ser1078Thr) AND not provided

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jan 28, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000183028.12

Allele description [Variation Report for NM_000335.5(SCN5A):c.3232T>A (p.Ser1078Thr)]

NM_000335.5(SCN5A):c.3232T>A (p.Ser1078Thr)

Genes:
LOC110121269:VISTA enhancer hs2177 [Gene]
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000335.5(SCN5A):c.3232T>A (p.Ser1078Thr)
Other names:
p.S1079T:TCC>ACC
HGVS:
  • NC_000003.12:g.38579489A>T
  • NG_008934.1:g.75184T>A
  • NG_053884.1:g.1228A>T
  • NM_000335.5:c.3232T>AMANE SELECT
  • NM_001099404.2:c.3235T>A
  • NM_001099405.2:c.3235T>A
  • NM_001160160.2:c.3232T>A
  • NM_001160161.2:c.3228+1442T>A
  • NM_001354701.2:c.3232T>A
  • NM_198056.3:c.3235T>A
  • NP_000326.2:p.Ser1078Thr
  • NP_001092874.1:p.Ser1079Thr
  • NP_001092875.1:p.Ser1079Thr
  • NP_001153632.1:p.Ser1078Thr
  • NP_001341630.1:p.Ser1078Thr
  • NP_932173.1:p.Ser1079Thr
  • NP_932173.1:p.Ser1079Thr
  • LRG_289t1:c.3235T>A
  • LRG_289:g.75184T>A
  • LRG_289p1:p.Ser1079Thr
  • NC_000003.11:g.38620980A>T
  • NM_198056.2:c.3235T>A
Protein change:
S1078T
Links:
dbSNP: rs376183542
NCBI 1000 Genomes Browser:
rs376183542
Molecular consequence:
  • NM_001160161.2:c.3228+1442T>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000335.5:c.3232T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099404.2:c.3235T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099405.2:c.3235T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160160.2:c.3232T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354701.2:c.3232T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198056.3:c.3235T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000235436GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Feb 19, 2018)
germlineclinical testing

Citation Link,

SCV001200425Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 28, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From GeneDx, SCV000235436.11

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

A variant of uncertain significance has been identified in the SCN5A gene. The S1079T variant has not been previously reported in association with cardiomyopathy or other SCN5A-related disorder, to our knowledge. The S1079T variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server; Kapplinger et al., 2015). However, the S1079T variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Additionally, this substitution occurs at a position that is not conserved across species and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Furthermore, while missense variants at the same residue (S1079F, S1079Y) have been previously reported in association with SCN5A-related disorders (Itoh et al., 2010; Kapplinger et al., 2010), the clinical significance of these variants also remain to be definitively determined.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV001200425.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 1079 of the SCN5A protein (p.Ser1079Thr). This variant is present in population databases (rs376183542, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SCN5A-related conditions. ClinVar contains an entry for this variant (Variation ID: 201491). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 2, 2024